CANbridge Pharmaceuticals Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	49.98	85.1	102.87	78.97	31.16
Revenue Growth (YoY)	-41.27%	-17.27%	30.26%	153.43%	158.98%
Cost of Revenue	13.43	30.8	38.71	30.08	12.39
Gross Profit	36.56	54.3	64.16	48.89	18.78
Selling, General & Admin	84.2	143.06	173.5	195.69	246.27
Research & Development	45.05	251.76	257.21	311.17	427.66
Operating Expenses	129.25	394.82	430.71	506.86	673.92
Operating Income	-92.7	-340.52	-366.55	-457.97	-655.15
Interest Expense	-2.23	-8.58	-8.95	-6.86	-3.08
Interest & Investment Income	0.37	0.51	10.98	3.89	2.61
Currency Exchange Gain (Loss)	8.23	-	-	-	0.63
Other Non Operating Income (Expenses)	-0.26	-12.56	-14.56	-22.97	30.69
EBT Excluding Unusual Items	-86.58	-361.15	-379.08	-483.91	-624.3
Gain (Loss) on Sale of Assets	1.09	6.5	-	0.44	9.73
Asset Writedown	-0.73	-87.99	-	-	-
Other Unusual Items	101.04	0.03	0.24	-	-462.44
Pretax Income	14.82	-442.62	-378.84	-483.48	-1,077
Net Income	14.82	-442.62	-378.84	-483.48	-1,077
Net Income to Common	14.82	-442.62	-378.84	-483.48	-1,077
Shares Outstanding (Basic)	454	425	424	424	94
Shares Outstanding (Diluted)	457	425	424	424	94
Shares Change (YoY)	7.55%	0.11%	0.04%	350.13%	37.39%
EPS (Basic)	0.03	-1.04	-0.89	-1.14	-11.43
EPS (Diluted)	0.03	-1.04	-0.89	-1.14	-11.43
Free Cash Flow	-	-122.5	-283.38	-296.18	-592.16
Free Cash Flow Per Share	-	-0.29	-0.67	-0.70	-6.28
Gross Margin	73.13%	63.81%	62.37%	61.91%	60.26%
Operating Margin	-185.46%	-400.12%	-356.32%	-579.91%	-2102.46%
Profit Margin	29.65%	-520.10%	-368.26%	-612.21%	-3456.26%
Free Cash Flow Margin	-	-143.94%	-275.47%	-375.04%	-1900.31%
EBITDA	-78.98	-326.8	-354.72	-448.84	-646.11
EBITDA Margin	-158.02%	-	-	-	-
D&A For EBITDA	13.72	13.72	11.82	9.13	9.04
EBIT	-92.7	-340.52	-366.55	-457.97	-655.15
EBIT Margin	-185.46%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.